Stock Events

Predictive Technology 

$0
7
+$0+0% Thursday 16:05

Statistics

Day High
0
Day Low
0
52W High
0.04
52W Low
0
Volume
2,500
Avg. Volume
36,501
Mkt Cap
90,000
P/E Ratio
0
Dividend Yield
-
Dividend
-

Earnings

30NovExpected
Q1 2021
Q2 2021
Q3 2021
Q4 2021
Q1 2022
Q2 2022
Q3 2022
-0.05
-0.03
-0.02
0
Expected EPS
0
Actual EPS
0

People Also Follow

This list is based on the watchlists of people on Stock Events who follow PRED. It's not an investment recommendation.

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.
Illumina
ILMN
Mkt Cap17.29B
Illumina provides genomic sequencing solutions and competes with Predictive Technology in the genomic analysis and diagnostics market.
Thermo Fisher Scientific
TMO
Mkt Cap206.16B
Thermo Fisher Scientific offers a wide range of biotechnology product development services, including genetic testing and analysis, directly competing with Predictive Technology's offerings.
Qiagen NV
QGEN
Mkt Cap9.38B
Qiagen is a provider of sample and assay technologies for molecular diagnostics, applied testing, academic and pharmaceutical research, competing in the same space as Predictive Technology.
Guardant Health
GH
Mkt Cap3.52B
Exact Sciences
EXAS
Mkt Cap8.22B
Exact Sciences focuses on molecular diagnostics, including cancer screening and detection, competing in the diagnostics market alongside Predictive Technology.
Pacific Biosciences of California
PACB
Mkt Cap356.79M
Pacific Biosciences offers sequencing systems that compete with Predictive Technology's genomic analysis products.
Bionano Genomics
BNGO
Mkt Cap36.68M
Bionano Genomics provides tools for genomic analysis, competing in the same niche as Predictive Technology for genomic and molecular diagnostic solutions.
Fulgent Genetics
FLGT
Mkt Cap587.11M
Fulgent Genetics offers comprehensive genetic testing and competes with Predictive Technology in the genetic diagnostics and personalized medicine market.
Myriad Genetics
MYGN
Mkt Cap2.25B
Myriad Genetics specializes in molecular diagnostic tests, competing with Predictive Technology in the field of genetic testing and personalized medicine.

About

Apparel/Footwear
Consumer Non-Durables
Predictive Technology Group, Inc., together with its subsidiaries, develops and commercializes discoveries and technologies involved in novel molecular diagnostic, therapeutic, and human cellular and tissue-based products (HCT/Ps). It operates in two segments, Human Cellular and Tissues Products (HCT/Ps); and Diagnostics and Therapeutics. The company provides FertilityDX, a genetic testing service for couples experiencing infertility; ARTguide, a genetic test for women experiencing infertility because of endometriosis and other genetic conditions; and regenerative medicine products, including AmnioCyte, AmnioCyte Plus, PolyCyte, and CoreCyte for use in regenerative medicine applications. It has a collaboration agreement with Atrin Pharmaceuticals LLC to develop molecular diagnostic tools to facilitate enhanced selection of cancer patients. The company was formerly known as Global Enterprises Group, Inc. and changed its name to Predictive Technology Group, Inc. in July 2015. Predictive Technology Group, Inc. was founded in 2005 and is headquartered in Salt Lake City, Utah.
Show more...
CEO
Employees
62
Country
US
ISIN
US74039H1023

Listings